Akero Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:AKRO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Mar 24	SellUS$18,443	Jonathan Young	Individual	651	US$28.33
13 Mar 24	SellUS$20,483	Catriona Yale	Individual	723	US$28.33
13 Mar 24	SellUS$20,511	William White	Individual	724	US$28.33
13 Mar 24	SellUS$55,782	Andrew Cheng	Individual	1,969	US$28.33
13 Mar 24	SellUS$17,536	Timothy Rolph	Individual	619	US$28.33
14 Dec 23	SellUS$11,273	Jonathan Young	Individual	543	US$20.76
14 Dec 23	SellUS$10,671	Timothy Rolph	Individual	514	US$20.76
14 Dec 23	SellUS$12,394	Catriona Yale	Individual	597	US$20.76
14 Dec 23	SellUS$33,797	Andrew Cheng	Individual	1,628	US$20.76
14 Dec 23	SellUS$12,684	William White	Individual	611	US$20.76
08 Dec 23	BuyUS$1,982,940	Logos Global Management, L.P.	Company	100,000	US$19.85
01 Dec 23	BuyUS$1,694,565	Logos Global Management, L.P.	Company	100,000	US$16.99
17 Nov 23	SellUS$440,259	Jonathan Young	Individual	30,000	US$14.68
08 Aug 23	BuyUS$1,051,475	Logos Global Management, L.P.	Company	25,000	US$42.06
01 Aug 23	BuyUS$2,362,234	Logos Global Management, L.P.	Company	55,000	US$43.26
23 Jun 23	SellUS$1,725,390	Catriona Yale	Individual	33,349	US$52.26
20 Jun 23	SellUS$180,235	William White	Individual	3,277	US$55.00
16 Jun 23	SellUS$2,101,066	Timothy Rolph	Individual	38,200	US$56.30
19 May 23	BuyUS$5,040,000	Logos Global Management, L.P.	Company	120,000	US$42.00

Insider Trading Volume

Insider Buying: AKRO insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of AKRO?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,944	0.0057%
Individual Insiders	1,203,856	1.74%
General Public	2,424,106	3.51%
Public Companies	2,525,252	3.65%
Hedge Funds	3,592,759	5.2%
VC/PE Firms	5,233,989	7.57%
Institutions	54,167,101	78.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.8%.

Top Shareholders

Top 25 shareholders own 78.66% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.57%	General Atlantic Service Company, L.P.	5,233,989	US$104.1m	193%	1.67%
7.41%	State Street Global Advisors, Inc.	5,122,895	US$101.9m	104%	no data
6.23%	Janus Henderson Group plc	4,306,401	US$85.7m	-4.02%	0.04%
6.05%	BlackRock, Inc.	4,180,507	US$83.2m	5.11%	no data
5.32%	T. Rowe Price Group, Inc.	3,675,924	US$73.1m	-3.52%	0.01%
5.2%	RTW Investments, LP	3,592,759	US$71.5m	0%	1.26%
4.59%	Alkeon Capital Management, LLC	3,172,209	US$63.1m	-0.1%	0.48%
4.46%	The Vanguard Group, Inc.	3,085,048	US$61.4m	2.42%	no data
4.17%	Wellington Management Group LLP	2,881,989	US$57.3m	248%	0.01%
3.65%	Pfizer Inc.	2,525,252	US$50.2m	0%	no data
3.42%	Baker Bros. Advisors LP	2,368,378	US$47.1m	0%	0.59%
2.78%	Yiheng Capital Management, L.P.	1,923,674	US$38.3m	57.5%	4.33%
2.42%	Tavistock Life Sciences	1,676,733	US$33.4m	0%	1.96%
2.32%	AllianceBernstein L.P.	1,607,691	US$32.0m	25.4%	0.01%
1.69%	Geode Capital Management, LLC	1,166,245	US$23.2m	5.7%	no data
1.6%	Redmile Group, LLC	1,109,476	US$22.1m	-37.3%	0.93%
1.56%	Rock Springs Capital Management LP	1,081,064	US$21.5m	-23.8%	0.6%
1.47%	Morgan Stanley, Investment Banking and Brokerage Investments	1,013,675	US$20.2m	184%	no data
1.4%	Perceptive Advisors LLC	967,775	US$19.2m	-40.2%	0.45%
1.16%	Logos Global Management, L.P.	800,000	US$15.9m	0%	1.98%
0.94%	Point72 Asset Management, L.P.	649,541	US$12.9m	934%	0.03%
0.86%	Oppenheimer Asset Management Inc.	592,011	US$11.8m	0%	0.07%
0.82%	Commodore Capital LP	565,000	US$11.2m	0%	0.77%
0.8%	Goldman Sachs Group, Investment Banking and Securities Investments	554,099	US$11.0m	123%	0.01%
0.78%	Northern Trust Global Investments	540,685	US$10.8m	0.49%	no data